Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
14.18 USD | -0.35% | +4.19% | -4.38% |
Apr. 25 | UBS Adjusts Sleep Number Price Target to $13 From $12, Maintains Neutral Rating | MT |
Apr. 25 | Piper Sandler Adjusts Price Target on Sleep Number to $13 From $12, Keeps Neutral Rating | MT |
Strengths
- The stock, which is currently worth 2024 to 0.14 times its sales, is clearly overvalued in comparison with peers.
- Given the positive cash flows generated by its business, the company's valuation level is an asset.
- The average price target of analysts who are interested in the stock has been strongly revised upwards over the last four months.
- The divergence of price targets given by the various analysts who make up the consensus is relatively low, suggesting a consensus method of evaluating the company and its prospects.
Weaknesses
- As estimated by analysts, this group is among those businesses with the lowest growth prospects.
- The company's profitability before interest, taxes, depreciation and amortization characterizes fragile margins.
- The company has insufficient levels of profitability.
- For the last twelve months, the trend in sales revisions has been clearly going down, which emphasizes downgraded expectations from the analysts.
- For the past year, analysts have significantly revised downwards their profit estimates.
- For the last twelve months, the analysts covering the company have given a bearish overview of EPS estimates, resulting in frequent downward revisions.
- The appreciation potential seems limited due to the average target prices set by the analysts covering the stock.
- Sales estimates for the next fiscal years vary from one analyst to another. This clearly highlights a lack of visibility into the company's future activity.
Ratings chart - Surperformance
Chart ESG Refinitiv
Sector: Home Furnishings
1st Jan change | Capi. | Investor Rating | ESG Refinitiv | |
---|---|---|---|---|
-4.38% | 317M | C | ||
-2.06% | 8.67B | B | ||
-4.20% | 3.79B | C- | ||
+5.08% | 2.22B | C | ||
+6.69% | 1.8B | - | ||
-10.32% | 1.41B | B- | ||
-27.03% | 1.18B | C+ | ||
+28.08% | 1.13B | - | ||
+4.35% | 928M | - | ||
-2.98% | 816M | - |
Financials
Valuation
Momentum
Consensus
Business Predictability
Environment
Governance
Controversy
Technical analysis
- Stock Market
- Equities
- SNBR Stock
- Ratings Sleep Number Corporation